Papillomavirus in cervical carcinoma

Authors

  • Hernán Cortés Yepes

DOI:

https://doi.org/10.18597/rcog.618

Keywords:

papillomavirus, cervical cancer, epidemiology, pathogenesis, viral proteins, vaccination

Abstract

The human papillomavirus (HPV) infection is the most common sexually transmitted disease in the world. The HPV is a necessary cause for the cervical cancer development, but is not enough, because other factors are involved in the infection to cancer progression. The HPV belongs to the Papovaviridae family, it is a DNA virus and is classified as a cutaneous and mucous virus. It is discussed the epidemiological evidence in the chance between HPV and cervical cancer and the oncogenic mechanisms of the virus.

Author Biography

Hernán Cortés Yepes

Ginecólogo y Obstetra, docente Departamento de Ginecología y Obstetricia. Universidad de Antioquia. Medellín-Colombia.

References

Muñoz N. Human Papillomavirus and cancer: the epidemiological evidence. Journal of Clinical Virology 2000;19:1-5.

Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8

Berek JS. Cervical cancer. En: Berek JS, Hacker NF. Practical Gynecology Oncology. 3th edition. Lippincot Williams & Wilkins; 2000. p. 180-203.

Instituto Nacional de Cancerología. Epidemiología cáncer en Colombia durante el año 1999 - 2000. Bogotá; 2000. (Documento web: www.incancerologia.gov.co).

Muñoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002;359:1093-101.

Moreno V, Bosch FX, Muñoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002;359:1085-192.

McMurray HR, Nguyen D, Westbrook TF, McAnce DJ. Biology of human papillomaviruses. Viruses and Cancer 2001;82:15-33.

Unger E, Duarte-Franco E. Human papillomaviruses. Into the new millennium. Obstet Gynecol Clin North Am 2001;28:653-6.

Tortolero-Luna G. Epidemiology of genital human papillomavirus. Hematol Oncol Clin of NA 1999;13:245-57.

Klyono T, Foster SA, Kopp JL, et al. Both Rb/p 161NK4a in activaction and telomerase activity are required to immortalize human epithelial cells. Nature 1998;396:84-8.

Straight SW, Herman B, McCance DJ. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 1995;69:3185-92.

Hildesheim A. HPV prophylactic vaccines. Handbook: Pathogenesis of human oncogenic viruses. ICGEB; 2002.

How to Cite

1.
Cortés Yepes H. Papillomavirus in cervical carcinoma. Rev. colomb. obstet. ginecol. [Internet]. 2003 Jun. 27 [cited 2024 May 18];54(2):107-12. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/618

Downloads

Download data is not yet available.

Published

2003-06-27

Issue

Section

Review Article
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo

Some similar items: